Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
   Stress, Anxiety, PTSD: 2 NASDAQ-Listed Drug Developers Advance Psychedelic-Inspired Meds
   
  
  
  April 20, 2023
  From Benzinga
 
   EXCLUSIVE: Bringing Decolonization, Trauma And Inclusion To The Fore Of Psychedelics Therapy
   
  
  April 17, 2023
  From Benzinga
 
   Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
   
  
  
  April 17, 2023
  From Benzinga
 
   80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial
   
  April 17, 2023
  Tickers 
   MNMD
  
  
  From Benzinga
 
   Atai Advances R-Ketamine Through Phase 1 Bridging Study, Update And Near-Term Expectations
   
  April 14, 2023
  Tickers 
   ATAI
  
  
  From Benzinga
 
   Safe And Affordable Access To Psychedelics Therapy: Several Organizations Sharing That Goal
   
  
  April 14, 2023
  From Benzinga
 
   Awakn's Psychedelics Medical Chief Steps Down, Shifts In Company's Stocks And Ownership
   
  April 14, 2023
  Tickers 
   AWKNF
  
  
  From Benzinga
 From Benzinga
 
   Psychedelics Reform Update: CT Psilocybin Decriminalization, Washington's Review And More
   
  
  April 13, 2023
  From Benzinga
 
   Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More
   
  
  
  April 11, 2023
  From Benzinga
 
   Bipartisan Letter Calls For Including Active Service Members In Psychedelic-Assisted Therapy Research
   
  
  April 10, 2023
  From Benzinga
 
   EXCLUSIVE: The Importance Of Attaining A Decolonized Perspective Of Psychedelics Therapy
   
  
  April 08, 2023
  From Benzinga
 
   Are Next-Gen Psychedelics The Incoming Solution For Mental Health? Learn It All At Benzinga's Psychedelics Capital Conference
   
  
  April 06, 2023
  From Benzinga
 From Benzinga
 
   UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage
   
  
  April 05, 2023
  From Benzinga
 
   Therapists At Mass General Hospital Prepared To Assist IBS Patients With Psilocybin Therapy
   
  April 04, 2023
  Tickers 
   TRYPF
  
  
  From Benzinga
 From Benzinga
 
   Are Psychedelics A Threat To Alcohol And Tobacco Industries? A Glance At Thriving Advances
   
  April 04, 2023
  Tickers 
   NFLX
  
  
  From Benzinga
 
   Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill
   
  
  
  April 03, 2023
  From Benzinga
 
   Psychedelics Reform Update: Rhode Island's Bipartisan Bill, Montana Proposal Gutted And More
   
  
  March 31, 2023
  From Benzinga
 From Benzinga
 
   High-Profile Highs: How Celebrity Advocacy Is Transforming Society's Views On Psychedelics And Cannabis
   
  
  
  March 29, 2023
  From Benzinga
 
   Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism
   
  
  March 28, 2023
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.